| DAA699 |
Triglyceride levels increase |
— |
plasma |
Human |
|
| DAA900 |
Urine concentrating capacity decreases |
— |
renal tubule |
Human |
|
| DAA966 |
Vaccination antibody response is impaired |
— |
immune system |
Human |
|
| DAA1061 |
Variability in clearance of hepatically metabolized drugs |
— |
liver |
Human |
|
| DAA2043 |
Variations in body weight |
— |
whole body |
Human |
|
| DAA2044 |
Variations in fat mass |
— |
adipose tissue |
Human |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
— |
renal vasculature |
Human |
|
| DAA794 |
Ventilatory rate at maximum exertion decreases |
— |
lung |
Human |
|
| DAA788 |
Viscoelastic modulus of brain tissue decreases |
— |
brain |
Human |
|
| DAA2583 |
Vision loss |
— |
visual apparatus |
Human |
|
| DAA1053 |
Cholesterol level - High (Female) |
SeriesIncidence |
plasma |
Human |
|
| DAA1052 |
Cholesterol level - High (Male) |
SeriesIncidence |
plasma |
Human |
|
| DAA1994 |
Increase in collagen in the arterial intima |
100.0% Increase Protein level |
arterial intima |
Human |
|
| DAA1995 |
Decrease in collagen in the venous intima |
42.0% Decrease Protein level |
venous intima |
Human |
|
| DAA1200 |
Inhibin levels decline |
Decrease Hormone Level |
plasma |
Human |
|
| DAA1199 |
Serum klotho |
Increase Hormone Level |
plasma |
Human |
|
| DAA1181 |
Morning IGF1 decline |
51.0% Decrease Hormone Level |
plasma |
Human |
|
| DAA1180 |
Morning concentrations of testosterone decline |
80.0% Decrease Hormone Level |
plasma |
Human |
|